Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acanthamoeba Keratitis
100%
Visual Outcome
55%
Risk Factors
50%
Superiority Trial
50%
Randomized Placebo-controlled Trial
50%
Nationwide Survey
50%
Intravitreal Dexamethasone
50%
Risk Functional
50%
Clinical Assessment
50%
Survey Assessment
50%
Treatment Failure
50%
Topical Corticosteroids
50%
Risk Assessment
50%
Anti-amoebic
50%
Intravitreal Antibiotics
50%
Bacterial Endophthalmitis
50%
Rising Incidence
50%
Functional Outcome
50%
After Cataract
50%
Cataract Surgery
50%
Placebo
37%
Soft Contact Lens
37%
Contact Lens Wearers
37%
Netherlands
37%
Best-corrected Visual Acuity
37%
Corticosteroids
30%
Cornea
25%
Corticosteroid Use
25%
Predictive Factors
25%
High Severity
25%
Preservatives
25%
Vancomycin
25%
Visual Acuity
25%
Diagnostic Delay
22%
Penetrating Keratoplasty
20%
Vitreous Biopsy
12%
Uncommon Diseases
12%
Medical Files
12%
Gentamicin
12%
Reflex
12%
Tertiary Care Hospital
12%
Regression Analysis
12%
Three-line
12%
Early Referral
12%
Decimals
12%
Age at Presentation
12%
Logistic Regression Analysis
12%
High Age
12%
Virulent Pathogens
12%
Diagnostic Methods
12%
Medicine and Dentistry
Acanthamoeba Keratitis
100%
Endophthalmitis
50%
Placebo
50%
Dexamethasone
50%
Clinical Assessment
50%
Topical Corticosteroid
50%
Antibiotics
50%
Cataract Surgery
50%
Soft Contact Lens
37%
Patient Referral
32%
Best Corrected Visual Acuity
26%
Diagnostic Delay
25%
Disease
25%
Penetrating Keratoplasty
25%
Visual Acuity
19%
Vancomycin
14%
Biopsy
14%
Logistic Regression Analysis
12%
Contact Lens
12%
Diagnostic Procedure
12%
Patient Characteristics
12%
Keratoplasty
12%
Steroid Therapy
12%
Case-Control Study
12%
Differential Diagnosis
12%
Disease Severity
12%
Medical Record
12%
Keratitis
12%
Cornea Edema
7%
Gentamicin
7%
Vitreous Biopsy
7%
Pathogen
7%
Adjuvant
7%
Intravitreal Administration
7%
Epileptic Absence
7%
Diagnosis
7%
Intention-to-Treat Analysis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Dexamethasone
50%
Endophthalmitis
50%
Acanthamoeba Keratitis
50%
Topical Corticosteroid
50%
Cataract
50%
Antibiotic Agent
50%
Placebo
50%
Vancomycin
14%
Disease Severity
12%
Keratitis
12%
Case-Control Study
12%
Disease
12%
Infectious Agent
7%
Intravitreal Administration
7%
Epileptic Absence
7%
Adjuvant
7%
Gentamicin
7%
Cornea Edema
7%